Post Lead Optimization
Identification of MoA for potential adverse events, incorporating
those elements into design of backup series and more
Molecular hypotheses for observed AEs
PK/PD QSAR models
In vitro – in vivo correlation (IVIVC) models
Back up series design based on learnings from primary series
Comprehensive review of the DMT cycle
Lead repurposing
What worked, what didn’t